Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress
PROVID-19
1 other identifier
interventional
268
2 countries
19
Brief Summary
The SARS-Cov2 viral pandemic is responsible for a new infectious disease called COVID-19 (CoronaVIrus Disease), is a major health problem. Respiratory complications occur in 15 to 40%, the most serious is acute respiratory distress syndrome (ARDS). The management of COVID-19 is essentially symptomatic with respiratory oxygen supplementation in mild forms to invasive mechanical ventilation in the most severe forms. Prone position (PP) reduced mortality in patients with ARDS in intensive care. Ding et al showed that PP and high flow oxygenation reduced the intubation in patients with moderate to severe ARDS. The investigators hypothesize that the use of PP in spontaneously ventilation patients under oxygen standard could decrease incidence of intubation or non-invasive ventilation or death compared to conventional positioning management in medical departments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable covid19
Started Aug 2020
Typical duration for not_applicable covid19
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2020
CompletedFirst Posted
Study publicly available on registry
April 27, 2020
CompletedStudy Start
First participant enrolled
August 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 13, 2022
CompletedDecember 28, 2022
December 1, 2022
1.4 years
April 22, 2020
December 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent age of patients who will have endotracheal intubation or non-invasive ventilation at two pressure levels and/or die, in each of the 2 randomization groups.
To show that PP in spontaneously ventilation patients could reduce the risk of acquiring the following event (composite endpoint): * Endotracheal intubation * Or non-invasive ventilation (NIV) with two pressure levels * And/or death
Day 28
Secondary Outcomes (8)
Duration in days for the change of 2 points on the WHO ordinal scale
Day 28
Rate (%) of intubation and invasive ventilation in the 2 randomization groups.
Day 28
Rate (%) of non-invasive ventilation at two pressure levels in the 2 randomization groups
Day 28
Duration of oxygen therapy in the 2 randomization groups.
Day 28
Duration of hospitalization in the 2 randomization groups.
Day 28
- +3 more secondary outcomes
Study Arms (2)
Conventional positioning
NO INTERVENTIONsemi-seated in bed or seated in a chair during the day. The prone position is not allowed during the day (it is allowed at night if it is the natural sleeping position).
Interventional positioning : prone position
EXPERIMENTALTwo sessions minimum of prone position over the day. With a total objective of at least 2h30 of cumulated duration over the day. The objective is to spend as much time as possible in prone position if the patient tolerates it well.
Interventions
Two sessions minimum of prone position over the day. With a total objective of at least 2h30 of cumulated duration over the day. The objective is to spend as much time as possible in prone position if the patient tolerates it well.
Eligibility Criteria
You may qualify if:
- Patients aged from 18 to 85 years old
- With COVID-19 documentation
- Undergoing oxygen therapy (nasal cannula, medium or high concentration mask or high flow nasal oxygen therapy)
- Able to move to PP by him/herself or with minimal assistance
- Written consent
- Hospitalized in COVID medical department for less than 72 hours
You may not qualify if:
- Pregnant (positive pregnancy test during screening) or breastfeeding women
- Patient on long-term oxygen therapy or Continuous Positive Airway Pressure (CPAP) or Non-Invasive Ventilation (NIV) at home
- Chronic Obstructive Pulmonary Disease (COPD) Patient stage 3 or 4
- Patient with known chronic diffuse interstitial lung disease
- Patient with neuromuscular pathology
- Contraindication to the PP (recent thoracic trauma, pneumothorax, orthopaedic fracture preventing mobilization, ...)
- Deep vein thrombosis of the lower limbs or pulmonary embolism with effective anticoagulation for less than 48 hours
- Hemodynamic instability (MAP \< 65 mm Hg) persisting for more than 1 hour
- Respiratory rate greater than 40 cycles per minute
- Excessive use of accessory respiratory muscles (as judged by the clinician)
- Indication for curative NIV (acute pulmonary edema or acute hypercapnic respiratory failure)
- Intestinal Occlusive Syndrome
- Patient unable to protect upper airway
- Inability to understand French or to follow instructions for the prone position.
- Person under guardianship
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (19)
CH de Blois
Blois, 41016, France
CH de DAX
Dax, 40100, France
CHD de VENDEE
La Roche-sur-Yon, 85925, France
CH de LA ROCHELLE
La Rochelle, 17019, France
CH Le Mans
Le Mans, 72037, France
CH Mont de MArsan
Mont-de-Marsan, 40012, France
CHR d'Orléans - Service Pneumologie
Orléans, 45000, France
CHR d'Orleans - Service Maladies Infectieuses
Orléans, 45067, France
HOPITAL LARIBOISIERE - Service diabétologie, endocrinologie, nutrition
Paris, 75010, France
Hopital Européen Georges Pompidou
Paris, France
Hopital Lariboisiere - Medecine Interne
Paris, France
Hopital Lariboisiere
Paris, France
CH de PERPIGNAN - Service Maladies infectieuses
Perpignan, 66046, France
Centre Hospitalier Intercommunal de Cornouaille - Quimper Concarneau
Quimper, 29000, France
CHRU de Tours - Service Médecine interne et immunologie Clinique
Tours, 37000, France
CHRU de Tours - Service Pneumologie
Tours, 37000, France
CHRU DE TOURS - Service Médecine interne et maladies infectieuses
Tours, 37044, France
CH Bretagne Atlantique
Vannes, 56017, France
centre Hospitalier Princesse Grace
Monaco, Monaco
Related Publications (6)
Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA. 2020 Apr 21;323(15):1499-1500. doi: 10.1001/jama.2020.3633. No abstract available.
PMID: 32159735BACKGROUNDHuang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
PMID: 31986264BACKGROUNDZhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
PMID: 32171076BACKGROUNDWu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
PMID: 32167524BACKGROUNDNay MA, Hindre R, Perrin C, Clement J, Plantier L, Seve A, Druelle S, Morrier M, Laine JB, Colombain L, Corvaisier G, Bizien N, Pouget-Abadie X, Bigot A, Jamard S, Nyamankolly E, Planquette B, Fossat G, Boulain T. Prone position versus usual care in hypoxemic COVID-19 patients in medical wards: a randomised controlled trial. Crit Care. 2023 Jun 17;27(1):240. doi: 10.1186/s13054-023-04529-z.
PMID: 37330512DERIVEDNay MA, Planquette B, Perrin C, Clement J, Plantier L, Seve A, Druelle S, Morrier M, Laine JB, Colombain L, Corvaisier G, Bizien N, Pouget-Abadie X, Bigot A, Bernard L, Nyamankolly E, Fossat G, Boulain T. Does awake prone positioning prevent the use of mechanical respiratory support or death in COVID-19 patients on standard oxygen therapy hospitalised in general wards? A multicentre randomised controlled trial: the PROVID-19 protocol. BMJ Open. 2022 Jul 8;12(7):e060320. doi: 10.1136/bmjopen-2021-060320.
PMID: 35803621DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mai-Anh NAY, Dr
CHR Orléans
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2020
First Posted
April 27, 2020
Study Start
August 28, 2020
Primary Completion
January 13, 2022
Study Completion
January 13, 2022
Last Updated
December 28, 2022
Record last verified: 2022-12